A Clinical Trial to study the effect of the Drug Moolaroga chooranam in patients having bleeding in the anus

A clinical study on Ratthamoolam with the evaluation of Siddha drug Moolaroga chooranam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008568

Enrollment

Registered

2017-05-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Ratthamoolam (Bleeding Piles)

Interventions

Intervention1: Moolaroga chooranam: 2 grams of Moolaroga chooranam is administered twice a day with honey for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who are having classical symptoms of bleeding piles(1st degree internal haemorrhoids) i.e constipation 2.Bleeding per anus 3.Itching in the perianal region. 4.Patients who are all willing to give blood samples at subsequent visit are involved in this study

Exclusion criteria

Exclusion criteria: 1.Patients of age below 18 above 60 years 2.Patient having 2nd ,3rd degree internal haemorrhoids 3.Pregnancy 4.Fissure in ano 5.External haemorrhoids 6.Fistula in ano 7.Diabetes mellitus 8.Hypertension 9.Rectal carcinoma

Design outcomes

Primary

Measure	Time frame
outcome is mainly assessed by reduction in clinical symptoms i.e bleeding per anus and by comparing before and after treatment and questionnairesTimepoint: 48 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr B Anbarasan

Govt Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026